Cited by 48Protein Kinase Regulation and GTPase SignalingMicrotubule and mitosis dynamicsMelanoma and MAPK Pathways

Microtubule Integrity Regulates Pak Leading to Ras-independent Activation of Raf-1

Open access
Zang, Mengwei, Waelde, Christine A., Xiang, Xiaoqin, Rana, Aja, Wen, Rong, Luo, Zhijun·2001·Journal of Biological Chemistry

Abstract

Growth factors activate Raf-1 by engaging a complex program, which requires Ras binding, membrane recruitment, and phosphorylation of Raf-1. The present study employs the microtubule-depolymerizing drug nocodazole as an alternative approach to explore the mechanisms of Raf activation. Incubation of cells with nocodazole leads to activation of Pak1/2, kinases downstream of small GTPases Rac/Cdc42, which have been previously indicated to phosphorylate Raf-1 Ser(338). Nocodazole-induced stimulation of Raf-1 is augmented by co-expression of small GTPases Rac/Cdc42 and Pak1/2. Dominant negative mutants of these proteins block activation of Raf-1 by nocodazole, but not by epidermal growth factor (EGF). Thus, our studies define Rac/Cdc42/Pak as a module upstream of Raf-1 during its activation by microtubule disruption. Although it is Ras-independent, nocodazole-induced activation of Raf-1 appears to involve the amino-terminal regulatory region in which the integrity of the Ras binding domain is required. Surprisingly, the Raf zinc finger mutation (C165S/C168S) causes a robust activation of Raf-1 by nocodazole, whereas it diminishes Ras-dependent activation of Raf-1. We also show that mutation of residues Ser(338) to Ala or Tyr(340)-Tyr(341) to Phe-Phe immediately amino-terminal to the catalytic domain abrogates activation of both the wild type and zinc finger mutant Raf by both EGF/4beta-12-O-tetradecanoylphorbol-13-acetate and nocodazole. Finally, an in vitro kinase assay demonstrates that the zinc finger mutant serves as a better substrate of Pak1 than the wild type Raf-1. Collectively, our results indicate that 1) the zinc finger exerts an inhibitory effect on Raf-1 activation, probably by preventing phosphorylation of (338)SSYY(341); 2) such inhibition is first overcome by an unknown factor binding in place of Ras-GTP to the amino-terminal regulatory region in response to nocodazole; and 3) EGF and nocodazole utilize different kinases to phosphorylate Ser(338), an event crucial for Raf activation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m100152200

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacologically perturbing microtubule dynamics resulted in changes of RAF-1 activation, which was further enhanced by mutations targeting the RAF-1 C1 domain.

    “Pharmacologically perturbing microtubule dynamics resulted in changes of RAF-1 activation, which was further enhanced by mutations targeting the RAF-1 C1 domain.”

    From Structural basis of microtubule-mediated signal transduction (2026) · cites this paper as [93]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 11

  1. [1]1. Rapp, U.R. ∙ Cleveland, J.L. ∙ Bonner, T.I. ... Reddy, E.P. ∙ Skalka, A.M. ∙ Curran, T. (Editors) The Oncogene Handbook Elsevier Science Publishers B.V., Amsterdam, 1988; 213-253 Google Scholar
  2. [2]2. Avruch, J. ∙ Zhang, X.F. ∙ Kyriakis, J.M. Trends Biochem. Sci. 1994; 19:279-283 Full Text (PDF) Scopus (569) PubMed Google Scholar
  3. [3]3. Morrison, D.K. ∙ Cutler, Jr., R.E. Curr. Opin. Cell Biol. 1997; 9:174-179 Crossref Scopus (544) PubMed Google Scholar
  4. [4]4. Tzivion, G. ∙ Luo, Z. ∙ Avruch, J. Nature. 1998; 394:536-539 Crossref Scopus (402) Google Scholar
  5. [5]5. Thorson, J.A., Yu, L.W.K. ∙ Hsu, A.L. ∙ Shih, N.-Y. ... Mol. Cell. Biol. 1998; 18:5229-5238 Crossref Scopus (192) PubMed Google Scholar
  6. [6]6. Schulte, T.W. ∙ Blagosklonny, M.V. ∙ Romanova, L. ... Mol. Cell. Biol. 1996; 16:5839-5845 Crossref Scopus (257) PubMed Google Scholar
  7. [7]7. Stanton, Jr., V.P. ∙ Nichols, D.W. ∙ Laudano, A.P. ... Mol. Cell. Biol. 1989; 9:639-647 Crossref Scopus (229) PubMed Google Scholar
  8. [8]8. Heidecker, G. ∙ Huleihel, M. ∙ Cleveland, J.L. ... Mol. Cell. Biol. 1990; 10:2503-2512 Crossref Scopus (206) PubMed Google Scholar
  9. [9]9. Zhang, X.F. ∙ Settleman, J. ∙ Kyriakis, J.M. ... Nature. 1993; 364:308-313 Crossref Scopus (807) PubMed Google Scholar
  10. [10]10. Chuang, E. ∙ Barnard, D. ∙ Hettich, L. ... Mol. Cell. Biol. 1994; 14:25-5318 Crossref Scopus (169) Google Scholar
  11. [11]11. Scheffler, J.E. ∙ Waugh, D.S. ∙ Bekesi, E. ... J. Biol. Chem. 1994; 269:22340-22346

Cited by

Sorted by citations

Authors
Zang, M., Waelde, C. A., Xiang, X., Rana, A., Wen, R., & Luo, Z.
Affiliations
  • Boston University (US)
  • Harvard University (US)
  • University of Pennsylvania (US)
Corresponding author
Luo, Zhijun
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2001-01
Volume
276
Issue
27
Pages
25157-25165
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2004259745
Cited by
48
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2015: 2 · 2013: 1 · 2012: 2
FWCI
1.63
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institute of General Medical Sciences (R01GM057959, GM57959)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
Raf-1 activation, microtubule integrity, nocodazole, EGF signaling
MeSH terms
Animals, Electrophoresis, Polyacrylamide Gel, Enzyme Activation, Epidermal Growth Factor, Humans, Microtubules, Phosphorylation, Tetradecanoylphorbol Acetate, Nocodazole, Zinc Fingers, ras Proteins, COS Cells, Proto-Oncogene Proteins c-raf, Amino Acid Substitution, Catalytic Domain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review